Symbol
| FBN2
| contributors: mct - updated : 09-01-2018
|
HGNC name
| fibrillin 2
|
HGNC id
| 3604
|
corresponding disease(s)
|
CCA
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
|  
| loss of function
|
by promoter region methylation in primary renal cell carcinoma | tumoral
|  
|  
| --low
|  
|
silencing by methylation in esophageal squamous cell carcinoma | constitutional
|  
|  
| --over
|  
|
in bicuspid aortic valve (BAV) in the ascending aorta, irrespective of dilatation, whereas MMP expression does not change significantly | |
Susceptibility
|
to macular degeneratio |
Variant & Polymorphism
other
| rare and common variants in FBN2 are associated with macular degeneration |
|
|
Candidate gene
Marker
| FBN2, TNSC, MATN2, and MATN4 may be markers of the pathogenesis of either granular or lattice type I corneal dystrophy | Therapy target
| | |
| Fbn2 null mice are born with reduced muscle mass, abnormal muscle histology, and signs of activated BMP signaling in skeletal muscle |